NovaBridge (NBP) Biosciences announced that Fu Wei, Executive Chairman of the Board, intends to purchase up to $5,000,000 of the Company’s ADSs in open market transactions. The purchases started on January 15 and are ongoing as of the date of this press release. As the planned purchases are to be executed by Fu Wei via his controlled entity, NovaBridge cannot guarantee the number of ADSs to be purchased or the time frame in which the ADSs will be bought in the open market.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NBP:
- NovaBridge Biosciences Executive Chairman Begins Up to $5 Million Open-Market ADS Purchase
- Reiterating Buy on NovaBridge: Strong Phase 1b Givastomig Data, Manageable Safety, and Attractive Entry Point Support $9 Target
- NovaBridge Posts Strong Phase 1b Givastomig Data and Prepares Global Phase 2 in First-Line Gastric Cancer
- NovaBridge presents dose expansion data from Phase 1b study of givastomig
- NovaBridge Biosciences Files Nine-Month 2025 Results and Updates Investors on Strategic Transition